text,size,topic
coronavirus_sars,12,5
pharmaceutical_application,10,5
coronavirus_pneumonia,66,5
biological_medicines,157,5
pharmaceutical_composition,171,5
virus_infection,15,5
small_interfering_nucleic,20,5
small_interfering_nucleic_acid,20,5
quality_control,15,5
active_ingredient,15,5
small_interfering,20,5
respiratory_diseases,14,5
coronavirus_gene,23,5
viral_infection,28,5
coronavirus_gene_expression,10,5
viral_infections,22,5
